Fact-checked by Grok 2 weeks ago

Iodoform

Iodoform, also known as triiodomethane (CHI₃), is a pale , crystalline organoiodine compound with a molecular weight of 393.73 g/mol, notable for its distinctive saffron-like and volatility. It appears as a bright or crystals, melts at 119–122 °C, sublimes at 218 °C, and exhibits low in (<1 mg/mL) but good solubility in organic solvents like ethanol, ether, and chloroform. Discovered in 1822 by French chemist Georges Serullas through the reaction of iodine vapor with steam over red-hot coals, iodoform's antiseptic properties were identified in 1880, leading to its widespread adoption in medical practice during the late 19th and early 20th centuries. It gained prominence as a disinfectant due to its ability to slowly release free iodine, which denatures bacterial proteins and exhibits mild antimicrobial activity without significant irritation. Historically, iodoform served as a key antiseptic in surgical and dental applications, including wound dressings, cavity packing for conditions like dry socket, and formulations such as (introduced in 1891) and (BIPP, developed in 1916 for World War I wound care). It promotes granulation tissue formation, destroys microbial toxins, and remains stable in oral fluids and blood, making it suitable for secondary wound healing in ulcers, cysts, and postoperative sites when mixed with agents like glycerine or eucalyptus oil. In chemistry, iodoform is central to the , a qualitative reaction used to detect methyl ketones or alcohols that can be oxidized to methyl ketones, producing the characteristic yellow precipitate. Although its use has declined since the mid-20th century in favor of safer, more effective antiseptics due to potential toxicity—including skin/eye irritation, allergic reactions (1–12% incidence), and risks to the liver, kidneys, or fetus in pregnancy—iodoform persists in niche applications like ENT surgery, neurosurgery, oral/maxillofacial procedures, and veterinary disinfectants for lesions. It is synthesized industrially from , , , and , and is classified as harmful if swallowed or inhaled but non-carcinogenic.

Nomenclature and structure

Nomenclature

Iodoform is the retained trivial name for the organoiodine compound with the molecular formula CHI3. The term "iodoform" originates from the prefix "iodo-" denoting iodine combined with "-form," derived from "formyl," referring to the formyl group (HCO–), reflecting its historical association with formyl derivatives. This naming convention parallels the haloform series, which includes chloroform (retained name for trichloromethane, CHCl3), bromoform (retained name for tribromomethane, CHBr3), and iodoform as the trihalogenated methane analogs where chlorine, bromine, or iodine replaces hydrogen atoms. The preferred IUPAC name for CHI3 is triiodomethane, emphasizing the systematic substitution of three iodine atoms on a methane backbone. Other synonymous names include carbon triiodide and methyl triiodide, which highlight the carbon-iodine composition or the methyl group's implied structure. These alternative designations are used in various chemical contexts but do not supersede the retained or preferred IUPAC nomenclature for formal identification.

Molecular structure

Iodoform has the chemical formula \ce{CHI3}. The molecule features a central carbon atom covalently bonded to one hydrogen atom and three iodine atoms via single bonds. In its Lewis structure, the carbon atom serves as the central atom with four sigma bonds and no lone pairs, while each iodine atom possesses three lone pairs of electrons to satisfy the octet rule. The three-dimensional arrangement adopts a tetrahedral molecular geometry with C_{3v} point group symmetry, where the central carbon is at the tetrahedron's center, the hydrogen occupies one vertex, and the three iodine atoms occupy the remaining vertices. The C–I bond lengths are approximately 213 pm, and the H–C–I bond angle is about 109.5°, consistent with the idealized tetrahedral configuration.

Properties

Physical properties

Iodoform is a pale yellow to bright yellow crystalline solid or powder with a pungent, disagreeable odor often described as saffron-like. The compound exhibits noticeable volatility at room temperature due to its vapor pressure of approximately 0.04 mmHg, resulting in a detectable vapor. Key physical properties of iodoform under standard conditions are summarized below:
PropertyValue
Molecular weight393.73 g/mol
Melting point119–122 °C
Boiling point218 °C (sublimes)
Density4.008 g/cm³ at 25 °C
Solubility in water0.01 g/100 mL at room temperature
Solubility in organic solventsSoluble in (7.8 g/100 mL), (13.6 g/100 mL), and
These properties reflect iodoform's high iodine content, which contributes to its characteristic yellow color.

Chemical properties

Iodoform exhibits good stability under normal ambient conditions, remaining unchanged at room temperature and pressure when protected from light. However, it decomposes upon heating above its melting point, releasing iodine vapor and forming hydrogen iodide gas along with carbon residues or trace hydrocarbons. Due to the relatively weak C-I bonds (bond dissociation energy approximately 234 kJ/mol), iodoform serves as a convenient source of iodide ions in various chemical processes. This bond weakness also renders it sensitive to strong bases and oxidizing agents, leading to potential cleavage or substitution under such conditions. The methine hydrogen atom in iodoform possesses moderate acidity, enabling deprotonation by strong bases to generate the corresponding carbanion. In infrared spectroscopy, iodoform displays characteristic C-I stretching vibrations between 500 and 600 cm⁻¹. Nuclear magnetic resonance spectroscopy reveals a distinctive singlet for the methine proton in the ¹H NMR spectrum at approximately δ 6.8–7.2 ppm (in CDCl₃), reflecting the deshielding effect of the iodine atoms.

Synthesis and occurrence

Synthetic methods

Iodoform is produced industrially via the using as the substrate, with generated in situ from and in the presence of . This method allows for efficient large-scale production by controlled addition of reagents to avoid excess . The primary laboratory synthesis of () utilizes the , involving the oxidative cleavage of or alcohols that can be oxidized to , such as or , in the presence of and a base like . For , the reaction proceeds as follows: \ce{CH3COCH3 + 3I2 + 4NaOH -> CHI3 + CH3COONa + 3NaI + 3H2O} This process involves the sequential iodination of the methyl group followed by nucleophilic attack by hydroxide, leading to the cleavage and formation of the carboxylate salt and iodoform precipitate. Similarly, undergoes initial oxidation to , which then follows the haloform pathway: \ce{CH3CH2OH + 3I2 + 4NaOH -> CHI3 + HCOONa + 3NaI + 3H2O} The procedure typically entails dissolving the substrate (e.g., 10-20 mL or ) in aqueous (10-20%), adding iodine crystals or with an portionwise while warming gently (around 60°C) to maintain the reaction, often over 30-60 minutes until the iodine color persists no longer. The yellow iodoform precipitate forms and is isolated by , washed with cold water, and dried. Another method involves electrolysis of a potassium iodide (KI) solution containing acetone or and , where anodic oxidation generates hypoiodite to drive the ; typical conditions use a anode and cathode at low current (1-2 A) for 1-2 hours, yielding the yellow precipitate directly. Laboratory syntheses via the generally afford high yields of 80-90% after purification, with the crude product often recrystallized from or to achieve purity greater than 95%. The electrolytic method can reach current efficiencies near 98%, though overall yields depend on substrate concentration and electrolysis duration. These methods emphasize controlled conditions to minimize side reactions like over-iodination.

Natural occurrence

Iodoform occurs naturally in limited biological sources, primarily associated with specific fungi and marine bacteria. It is found in the angel's bonnet mushroom (Mycena arcangeliana), a saprotrophic fungus that grows on dead wood, where the compound imparts its distinctive medicinal odor. Strains of the marine bacterium Roseovarius spp., isolated from coastal environments, produce iodoform as part of their metabolism of iodine compounds. These bacteria generate free iodine and organic iodine derivatives, including iodoform, through enzymatic processes involving iodide oxidation. Reports of iodoform production by microorganisms remain scarce, and its presence in natural seawater is typically at trace levels.

Reactions

Iodoform reaction

The iodoform reaction is a variant of the , in which methyl ketones of the form RCOCH₃ or alcohols oxidizable to such ketones, such as RCH(OH)CH₃, undergo cleavage in the presence of iodine (I₂) and (NaOH) to yield iodoform (CHI₃) and the sodium salt of a (RCOONa). This process was first observed in 1822 by Georges-Simon Serullas during studies of iodine reactions with alkaline solutions. The mechanism proceeds in two main stages: exhaustive α-halogenation followed by nucleophilic cleavage. Under basic conditions, the methyl ketone forms an enolate ion via at the α-carbon, which reacts with iodine to introduce three iodine atoms, forming a triiodomethyl ketone (RCOCI₃). This intermediate then undergoes nucleophilic attack by ion (OH⁻), leading to C-C bond cleavage and release of the triiodomethyl anion (⁻CI₃), which protonates to iodoform; the remaining forms the . Enolization is typically the rate-limiting step in iodoform reactions due to the lower reactivity of iodine compared to other . As a qualitative test, the iodoform reaction detects the presence of methyl ketone or functionalities in organic compounds, producing a characteristic precipitate of iodoform and discharge of the initial iodine color. The procedure involves adding a sample (typically 2-3 drops or 10-15 mg) to 2-3 mL of water or ethanol, followed by 10 drops of iodine-potassium iodide solution (KI/I₂) and dropwise addition of 10% NaOH until the solution turns colorless, often with gentle heating (60-70°C) for 5-10 minutes; a positive result appears as a precipitate or oily layer, sometimes accompanied by an . The test is specific to compounds containing the CH₃CO- group (as in methyl ketones like acetone, CH₃COCH₃) or the CH₃CH(OH)- group (as in primary alcohols like , CH₃CH₂OH, which oxidizes in situ to , CH₃CHO, or secondary alcohols like 2-propanol, CH₃CH(OH)CH₃, which oxidizes to acetone); itself also gives a positive response, yielding iodoform and . For instance, acetone reacts to form iodoform and , while produces iodoform via its oxidation to . This specificity distinguishes these structural motifs from other carbonyl compounds lacking the adjacent to the carbonyl.

Other reactions

Iodoform exhibits several additional chemical transformations due to its weak carbon-iodine bonds, which facilitate and processes. One notable reaction is its to diiodomethane (CH₂I₂), achieved by treatment with red and hydriodic acid; this stepwise replaces one iodine atom while preserving the diiodo structure. Alternatively, iodoform can be reduced to using sodium in the presence of , as described in synthetic procedures for preparing the reagent. In aqueous alkaline conditions, iodoform undergoes hydrolysis to produce formate and iodide ions. The reaction proceeds as follows: \text{CHI}_3 + 4\text{OH}^- \rightarrow \text{HCOO}^- + 3\text{I}^- + 2\text{H}_2\text{O} This base-catalyzed cleavage mirrors the reverse of the final step in the haloform reaction mechanism and requires heating with strong alkali for completion. Iodoform reacts readily with silver nitrate in aqueous solution, forming a bright yellow precipitate of silver iodide (AgI), which is utilized in quantitative gravimetric analysis. The stoichiometry indicates that 1 gram of AgI corresponds to approximately 0.5590 grams of iodoform, highlighting its utility in analytical chemistry. Exposure to light induces photochemical decomposition of iodoform, leading to the release of iodine (I₂) through of the C-I bonds. This process generates reactive intermediates such as the and iodine atoms, with potential applications in photochemical , and is evidenced by iodoform's absorption of above 290 nm.

Applications

Medical uses

Iodoform exhibits properties through the slow release of free iodine, which exerts a bactericidal effect by denaturing bacterial proteins and oxidizing essential cellular components. This mechanism, activated by wound secretions or enzymes like , allows for sustained action without rapid depletion. Historically, iodoform has been employed as a healing and antiseptic agent in wound dressings and powders since the early 20th century, particularly for treating sores and surgical sites. Iodoform-impregnated gauze was commonly used to pack surgical cavities, such as those from abscess drainage or dental extractions, promoting granulation tissue formation while absorbing exudate and preventing infection. In oral surgery, it effectively reduced bacterial colonization on sutures and aided in managing post-operative wounds. In , iodoform remains a key component in pastes and powders for disinfection and treatment of conditions like dry socket, often combined with or glycerin to enhance penetration and soothing effects. These formulations provide localized activity, helping to eliminate residual bacteria and facilitate healing in endodontic procedures. Contemporary medical applications of iodoform are limited due to the availability of safer, more effective alternatives like or , rendering it uncommon in general human wound care. However, it persists in specialized human contexts such as surgery, , and oral/maxillofacial procedures, as well as for ear powders in dogs and cats to prevent infections during hair removal and aural treatments, and in some settings for managing chronic skin ulcers and infections where modern antiseptics may be less accessible.

Other applications

Iodoform serves as a key analytical in organic qualitative analysis, particularly through the iodoform test, which detects the presence of methyl ketones or by producing a characteristic yellow precipitate of iodoform itself when the sample is treated with iodine and base. This test is widely employed in settings to identify compounds with a CH₃CO- group. In industrial applications, iodoform functions as a transfer agent in radical polymerizations, enabling controlled synthesis of polymers such as poly(methyl acrylate) and by regulating chain growth and molecular weight distribution. It is also utilized as a control agent and component in adhesives, where it contributes to the stability and performance of polymer-based formulations under regulatory standards for food-contact materials. Additionally, iodoform acts as a sensitizing agent in certain processes, enhancing the reactivity of photochemical systems. Modern niche applications include its role as an initiator in living of , facilitating the production of with narrow polydispersity indices at ambient temperatures.

History

Discovery

Iodoform, chemically known as triiodomethane (CHI₃), was first discovered in 1822 by the Georges-Simon Serullas during his investigations into the compounds of iodine, a recently isolated element. This breakthrough occurred amid early 19th-century explorations of chemistry, building on the 1811 discovery of iodine itself and preceding similar findings for other haloforms like in 1831. Serullas's work represented one of the initial forays into synthesizing halogenated hydrocarbons, highlighting the reactivity of iodine with organic substrates under specific conditions. Serullas achieved the initial synthesis of iodoform by passing a of iodine vapor and over red-hot coals, which yielded the compound as a distinctive product. In a related experiment detailed in the same study, he also produced iodoform through the reaction of metal with a of iodine in aqueous , resulting in a yellow precipitate he termed "hydroiodide of carbon." These methods marked the serendipitous identification of what would later be recognized as the , though Serullas did not fully elucidate the mechanism at the time. Early observations of iodoform emphasized its pale yellow crystalline appearance and volatility, characteristics noted by Serullas and confirmed by contemporaries in the chemical community. These properties distinguished it from other iodine derivatives and sparked interest in its potential applications, though initial focus remained on its chemical novelty rather than practical uses.

Development and decline

Following the recognition of its antiseptic properties in 1880, iodoform gained rapid adoption among surgeons for antisepsis during operations, particularly in dressings where it supplanted earlier wet methods with dry to reduce risks. This marked a significant advancement in surgical practice amid the broader shift toward techniques in the late 19th century. By the early , iodoform reached its peak usage in worldwide, serving as a standard healing and agent in dressings and powders for wounds, sores, and surgical cavities, contributing to improved postoperative outcomes in an era before widespread antibiotics. Its distinctive yellow color and odor became hallmarks of routine hospital care, with applications extending to dental and veterinary settings for similar purposes. The prominence of iodoform began to wane in the post-1940s period as safer and more effective alternatives emerged, including antibiotics like penicillin introduced in the early 1940s and antiseptics such as developed in the 1950s, which offered broader-spectrum activity with fewer side effects. Additionally, accumulating evidence of iodoform's toxicity—manifesting as , systemic iodine overload, and reactions—further diminished its favorability by the 1960s, prompting restrictions on its extensive use in large wounds. Despite its decline, iodoform's role as an early organic iodinated influenced the development of subsequent compounds, such as in the mid-20th century, which retained iodine's benefits while mitigating toxicity through better solubility and controlled release. This legacy underscores iodoform's foundational impact on modern iodinated antiseptics still employed in targeted clinical scenarios.

Safety and toxicity

Health hazards

Iodoform can be absorbed through , dermal , or , with rapid uptake via denuded skin, wounds, or mucous membranes. The oral LD50 in rats is 355 mg/kg, indicating moderate . Acute exposure to iodoform primarily causes irritation to and eyes, often manifesting as redness, itching, or burning sensations upon . of its vapors may lead to respiratory distress, including irritation of the upper and potential coughing or . At higher exposure levels, narcotic-like effects such as , , , , and hallucinations have been reported, particularly when absorbed through wounds during topical use. Chronic exposure to iodoform may result in disruption due to iodine overload, with case reports documenting thyrotoxicosis and in affected individuals. It exhibits cytotoxic effects on cells, including macrophages, where high concentrations induce and inhibit in both direct and indirect exposures. Additionally, iodoform can cause dermal sensitization, leading to characterized by itching, rash, or eczema upon repeated exposure. Its volatile nature contributes to secondary exposure risks through inhalation of iodine vapors released during decomposition. Iodoform is contraindicated in individuals with known to it, as severe allergic reactions, including swelling and difficulty breathing, have been observed.

Regulatory aspects

Iodoform is subject to occupational exposure limits to protect workers from its irritant and toxic effects. The National Institute for Occupational Safety and Health (NIOSH) establishes a (REL) of 0.6 ppm (10 mg/m³) as a 10-hour time-weighted (TWA), with a skin notation indicating potential absorption through the skin. The (OSHA) has not set a specific (PEL) for iodoform but requires adherence to general industry standards for controlling exposure to hazardous chemicals, often referencing NIOSH or other guidelines. Under regulations, iodoform is classified under the Classification, Labelling and Packaging (CLP) Regulation (EC) No 1272/2008 as category 4 (oral and dermal; H302, H312), category 3 (; H331), Skin irritation category 2 (H315), Eye irritation category 2 (H319), Specific target organ toxicity – single exposure category 3, respiratory tract irritation (H335), and Hazardous to the aquatic environment acute and chronic category 2 (H411). It is not classified as a by major regulatory bodies, such as the International Agency for Research on Cancer (IARC) or the (ECHA), though iodine-containing compounds are subject to ongoing monitoring for potential endocrine and developmental effects. Handling protocols for iodoform emphasize and (PPE) to mitigate exposure risks. Operations involving iodoform should be conducted in a or well-ventilated area to prevent of vapors or dust. Required PPE includes chemical-resistant gloves, safety goggles or face shields, and protective clothing; respiratory protection may be necessary if exposure limits are exceeded. Storage must occur in tightly sealed containers in a cool, dry, well-ventilated area, separated from incompatible substances such as strong oxidizers, alkali metals, and reducing agents to avoid violent reactions. Disposal of iodoform is regulated as by the U.S. Environmental Protection Agency (EPA) under the (RCRA), due to its toxicity characteristic; generators must evaluate it per 40 CFR Part 261 and dispose of it through permitted treatment, storage, and disposal facilities. In consumer products, its use is restricted; for instance, the U.S. Food and Drug Administration (FDA) permits iodoform only as an indirect in limited applications, such as a polymerization-control agent in adhesives for food-contact materials, to minimize public exposure. These regulations stem from iodoform's irritant effects, ensuring safe occupational and environmental management.

References

  1. [1]
    Iodoform | CHI3 | CID 6374 - PubChem - NIH
    Iodoform is soluble in fatty acids and decomposes releasing iodine in nascent state (96,7% of iodine) when in contact with secretions or endodontic infections.
  2. [2]
    Iodoform in Surgical Practice: A Comprehensive Review of Its ... - NIH
    Dec 15, 2024 · Discovered by Georges Serullas in 1822, iodoform has a long-standing history in medical formulations due to its antimicrobial and antiseptic ...
  3. [3]
    Iodoform: A boon in disguise - Scientific Research Publishing
    It s antiseptic action discovered in 1880, which made it an important medicinal. It has no irritant action; it has antiseptic, disinfectant properties. In ...
  4. [4]
    Blue Book P-60-65 - IUPAC nomenclature
    The retained names 'bromoform' for HCBr3, 'chloroform' for HCCl3, and 'iodoform' for HCI3 are acceptable in general nomenclature. Preferred IUPAC names are ...
  5. [5]
    IODOFORM definition in American English - Collins Dictionary
    Definition of 'iodoform'. COBUILD frequency band. iodoform in American English. (aɪˈoʊdəˌfɔrm ). nounOrigin: iodo- + formyl. a yellowish, crystalline compound ...Missing: etymology | Show results with:etymology
  6. [6]
    Iodoform: Uses, Interactions, Mechanism of Action | DrugBank Online
    Jun 23, 2017 · Iodoform is an organoiodine compound with the formula CHI3 and a tetrahedral molecular geometry. It is a relatively water-insoluble yellow solid ...
  7. [7]
    Lewis Structure Generator - Iodoform (CHI3)
    Bonds are shown as lines between atoms: a single line for a single bond, double line for a double bond, and a triple line for a triple bond.
  8. [8]
    Experimental data for CHI 3 (Iodoform) - CCCBDB
    Calculated geometries for CHI3 (Iodoform). Bond descriptions. Examples: C-C single bond, C=C, double bond, C#C triple bond, C:C aromatic ...
  9. [9]
    Molecular Parameters - Carbon Compounds - Wired Chemist
    Molecular Parameters - Carbon Compounds ; CHI · iodoform, C-I 2.12 ± 0.04, ICI 113.0 ; CHN, hydrogen cyanide (HCN), C-H 1.068 C-N 1.156 ± 0.001 ...Missing: pm | Show results with:pm
  10. [10]
    Iodoform - NIOSH Pocket Guide to Chemical Hazards - CDC
    Iodoform ; Physical Description. Yellow to greenish-yellow powder or crystalline solid with a pungent, disagreeable odor. [antiseptic for external use].
  11. [11]
    Iodoform - an overview | ScienceDirect Topics
    Iodoform is a lemon-yellow-colored crystalline organic salt of iodine (CHI3), analogous to chloroform, with a saffron-like odor, used as an antiseptic. View ...
  12. [12]
    iodoform, 75-47-8 - The Good Scents Company
    Specific Gravity: 4.00800 @ 25.00 °C. ; Melting Point: 119.00 °C. @ 760.00 mm Hg ; Boiling Point: 218.00 °C. @ 760.00 mm Hg ; Vapor Pressure: 0.040000 mmHg ; Vapor ...
  13. [13]
  14. [14]
    Iodoform | 75-47-8 - ChemicalBook
    Jun 13, 2025 · Iodoform (CAS 75-47-8) has formula CHI3, melting point 119°C, boiling point 218°C, density 4.008 g/mL, and is a bright yellow to dark yellow ...Missing: IUPAC | Show results with:IUPAC
  15. [15]
    IR: alkyl halides - Organic Chemistry at CU Boulder
    C–Cl stretches appear from 850–550 cm-1, while C–Br stretches appear at slightly lower wavenumbers from 690-515 cm-1. In terminal alkyl halides, the C–H wag of ...Missing: iodoform | Show results with:iodoform
  16. [16]
    Iodoform(75-47-8) 1H NMR spectrum - ChemicalBook
    ChemicalBook Provide Iodoform(75-47-8) 1H NMR,IR2,MS,IR3,IR,1H NMR,Raman,ESR,13C NMR,Spectrum. ... Iodoform(75-47-8) 1H NMR. Product NameIodoform. CAS75-47-8.Missing: signals | Show results with:signals
  17. [17]
  18. [18]
    200 Years of The Haloform Reaction: Methods and Applications - 2024
    Sep 30, 2024 · Two other haloforms (so named because they produce formic acid on hydrolysis), chloroform and bromoform, were subsequently discovered by ...Missing: etymology | Show results with:etymology
  19. [19]
  20. [20]
    [PDF] "Carbon Tetrachloride". In: Kirk-Othmer Encyclopedia of Chemical ...
    hydroiodic acid at 130. ◦. C, iodoform [75-47-8], CHI3, is produced. Carbon tetrachloride is unaffected by gaseous fluorine at ordinary temperatures ...
  21. [21]
  22. [22]
    Synthesis of Iodoform | PDF | Iodine | Mole (Unit) - Scribd
    Rating 3.0 (2) Iodoform crystals were produced, found to have a 56.46% yield and a 120°C melting point matching the theoretical range of 119-121°C. The reaction involves ...
  23. [23]
    [PDF] A SIMPLIFIED ELECTROLYTIC PREPARATION OF IODOFORM ...
    They specified the use of a platinum anode and a nickel cathode. The starting solution was composed of sodium carbonate, potassium iodide, alcohol, and water.
  24. [24]
    Showing metabocard for Iodoform (HMDB0253528)
    Sep 11, 2021 · Iodoform, also known as carbon triiodide or CHI3, belongs to the class of organic compounds known as trihalomethanes. These are organic ...Missing: names etymology haloform
  25. [25]
    Production of free and organic iodine by Roseovarius spp.
    Previous studies have found that Pseudomonas iodooxidans isolated from marine aquaria oxidized iodide to iodine using a peroxidase; however, these studies did ...
  26. [26]
    200 Years of The Haloform Reaction: Methods and Applications - PMC
    Discovered in 1822, the haloform reaction is one of the oldest synthetic organic reactions. The haloform reaction enables the synthesis of carboxylic acids, ...
  27. [27]
  28. [28]
  29. [29]
    Functional Groups - The Iodoform Test - Harper College
    How to perform the test: Three drops of the compound to be tested are added to 3 ml of water and 10 drops of KI/I2 solution (a dark purple-brown solution). 10% ...
  30. [30]
    [PDF] Identification of an Unknown – Alcohols, Aldehydes, and Ketones
    In the iodoform test, the unknown is allowed to react with a mixture of excess iodine and excess hydroxide. Hydrogens alpha to a carbonyl group are acidic and ...Missing: haloform specificity
  31. [31]
  32. [32]
    Iodoform Reactions - Important Concepts and Tips for JEE - Vedantu
    Rating 4.2 (373,000) Reaction with Silver Nitrate: Iodoform produces a yellow precipitate of silver iodide when heated with silver nitrate alcohol. In this reaction, it behaves ...
  33. [33]
    Diiodomethane - an overview | ScienceDirect Topics
    Iodoform was reduced to diiodomethane by sodium arsenite (Equation (178) ... reduction of diferrocenyl ditelluride, was treated with diiodomethane in THF.
  34. [34]
    Iodoform (triiodomethane) - An Old, but Still Extremely Efficient ...
    May 20, 2019 · Its antiseptic action is due to the slow release of iodine under the action of catalase from wounds. Currently, it is widely used only in ...
  35. [35]
  36. [36]
    Iodoform - an overview | ScienceDirect Topics
    Iodoform antiseptic pomade was effective in reducing bacterial colonization on silk braided sutures after oral surgery.
  37. [37]
    Iodoform USP: Clinical Profile and Industrial Applications
    In dental applications, Iodoform paste is used for its disinfecting qualities, particularly in root canal treatments to combat infection and aid in healing.
  38. [38]
    Iodoform - an overview | ScienceDirect Topics
    It has long been used as an external disinfectant and wound dressing in general medical contexts, although it is now uncommon for a variety of reasons. It is ...
  39. [39]
    Iodoform | Allergic Contact Dermatitis Database
    Iodoform is found in ear powders for dogs and cats to facilitate hair removal and help prevent infection.Missing: medicine | Show results with:medicine
  40. [40]
  41. [41]
    Iodoform as a transfer agent in radical polymerizations - ScienceDirect
    Iodoform as a transfer agent in radical polymerizations. Author links ... Keywords. iodoform. transfer agent. radical polymerization. Recommended articles ...
  42. [42]
  43. [43]
  44. [44]
  45. [45]
    Iodoform | Antiseptic, Disinfectant, Antibacterial - Britannica
    Sep 29, 2025 · Iodoform's antiseptic action, discovered in 1880, made it an important medicinal, but it has been largely displaced by more effective ...
  46. [46]
    The Victorian Revolution in Surgery | Science
    Sterilization became the order of the day as hospitals installed autoclaves and water treatment equipment; dry iodoform dressings supplanted earlier wet ...
  47. [47]
    Iodoform in Surgical Practice: A Comprehensive Review of Its ...
    Dec 15, 2024 · Historical evolution. The synthesis of iodoform was first described in 1822 by Georges-Simon Serullas, a French professor of pharmacy, who ...
  48. [48]
    TOXIC PSYCHOSIS DUE TO IODOFORM - Psychiatry Online
    Toxic psychosis due to iodoform hypersensitivity is uncommon and is rarely recognized. It generally occurs when the drug is painted on large surfaces which ...
  49. [49]
    (PDF) The Role of Iodine in Antisepsis and Wound Management
    Aug 6, 2025 · For more than 150 years, iodine has been used for the prevention of infection and for the treatment of wounds. Nowadays a large amount of ...Missing: influence iodinated
  50. [50]
    [PDF] Iodoform - Safety Data Sheet - ChemicalBook
    Information on toxicological effects. Acute toxicity. LD50 Oral - Rat - 355 mg/kg. Remarks: Behavioral:Altered sleep time (including change in righting reflex) ...
  51. [51]
    [PDF] workplace exposure limits - NJ.gov
    HAZARD SUMMARY. * Iodoform can affect you when breathed in and by passing through your skin. * Contact can irritate the skin and eyes.Missing: narcotic | Show results with:narcotic
  52. [52]
    [PDF] SAFETY DATA SHEET - Lab Alley
    Feb 20, 2025 · Toxic to aquatic organisms; may cause long-term adverse effects in the aquatic environment. Product. Species. Test Results. Iodoform. LC50.
  53. [53]
    Iodoform induced thyrotoxicosis in the elderly: case report and ...
    Dec 15, 2019 · Background. Drug-induced hyperthyroidism is a rare condition linked to dietary supplements, iodine-containing medications and intentional or ...
  54. [54]
    Iodoform: Neurologic impairment and hypothyroidism: 2 case reports
    Jun 12, 2021 · In a case series, a 56-year old man and a 64-year-old man were described, who developed neurologic impairment and hypothyroidism during ...
  55. [55]
    Cytotoxicity and proliferative effects of Iodoform-containing root ...
    Conclusions: Direct and indirect exposure to high concentrations of iodoform-containing root canal filling material showed a cytotoxic effect on macrophages and ...
  56. [56]
    Avoidance of BIPP allergy hypersensitivity reactions following ear ...
    The component part responsible is iodoform not iodine. We recommend patch testing patients previously exposed to BIPP undergoing ear surgery, if postoperative ...
  57. [57]
    Allergic reaction after iodoform-containing intracanal medication ...
    Sep 28, 2025 · This report presents a rare case of severe allergic reaction to iodoform following endodontic root canal treatment. A 24-year-old healthy female ...
  58. [58]
    IODOFORM | Occupational Safety and Health Administration - OSHA
    Dec 31, 2020 · Boiling point, 424°F (sublimes) ; Molecular weight, 393.73 ; Freezing point/melting point, 246°F ; Flash point, Vapor density ; Vapor density, 4.1.<|control11|><|separator|>
  59. [59]
    Iodoform Triiodomethane USP Grade n Pure Manufacturers, with SDS
    Classification according to EU Directives 67/548/EEC or 1999/45/EC: Xn = Harmful Xi = Irritant N = Dangerous for the environment. R20/22 Harmful by inhalation ...
  60. [60]
    [PDF] SAFETY DATA SHEET - Fisher Scientific
    Nov 9, 2009 · Acute Inhalation Toxicity - Dusts and Mists ... Delayed and immediate effects as well as chronic effects from short and long-term exposure.